| dc.creator | Sandoval, Lisette | |
| dc.creator | Fuentealba, Luz M. | |
| dc.creator | Marzolo, María-Paz | |
| dc.date | 2024-04-10T05:53:33Z | |
| dc.date | 2024-04-10T05:53:33Z | |
| dc.date | 2022 | |
| dc.date.accessioned | 2024-07-17T21:12:42Z | |
| dc.date.available | 2024-07-17T21:12:42Z | |
| dc.identifier | 10.3389/fcell.2022.911664 | |
| dc.identifier | 2296634X | |
| dc.identifier | https://hdl.handle.net/20.500.12728/10844 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/9509349 | |
| dc.description | Megalin/LRP2 is the primary multiligand receptor for the re-absorption of low molecular weight proteins in the proximal renal tubule. Its function is significantly dependent on its endosomal trafficking. Megalin recycling from endosomal compartments is altered in an X-linked disease called Lowe Syndrome (LS), caused by mutations in the gene encoding for the phosphatidylinositol 5-phosphatase OCRL1. LS patients show increased low-molecular-weight proteins with reduced levels of megalin ectodomain in the urine and accumulation of the receptor in endosomal compartments of the proximal tubule cells. To gain insight into the deregulation of megalin in the LS condition, we silenced OCRL1 in different cell lines to evaluate megalin expression finding that it is post-transcriptionally regulated. As an indication of megalin proteolysis, we detect the ectodomain of the receptor in the culture media. Remarkably, in OCRL1 silenced cells, megalin ectodomain secretion appeared significantly reduced, according to the observation in the urine of LS patients. Besides, the silencing of APPL1, a Rab5 effector associated with OCRL1 in endocytic vesicles, also reduced the presence of megalin’s ectodomain in the culture media. In both silencing conditions, megalin cell surface levels were significantly decreased. Considering that GSK3ß-mediated megalin phosphorylation reduces receptor recycling, we determined that the endosomal distribution of megalin depends on its phosphorylation status and OCRL1 function. As a physiologic regulator of GSK3ß, we focused on insulin signaling that reduces kinase activity. Accordingly, megalin phosphorylation was significantly reduced by insulin in wild-type cells. Moreover, even though in cells with low activity of OCRL1 the insulin response was reduced, the phosphorylation of megalin was significantly decreased and the receptor at the cell surface increased, suggesting a protective role of insulin in a LS cellular model. Copyright © 2022 Sandoval, Fuentealba and Marzolo. | |
| dc.description | Comisión Nacional de Investigación Científica y Tecnológica, CONICYT, (-21171004, AT24100200); Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (1200393); Fondo Nacional de Ciencia y Tecnología, FONACYT | |
| dc.format | application/pdf | |
| dc.format | application/pdf | |
| dc.format | application/pdf | |
| dc.language | en | |
| dc.publisher | Frontiers Media S.A. | |
| dc.subject | APPL1 | |
| dc.subject | GSK3 | |
| dc.subject | insulin | |
| dc.subject | lowe syndrome | |
| dc.subject | megalin | |
| dc.subject | ocrl1 | |
| dc.subject | proteolysis | |
| dc.subject | renal disease | |
| dc.title | Participation of OCRL1, and APPL1, in the expression, proteolysis, phosphorylation and endosomal trafficking of megalin: Implications for Lowe Syndrome | |
| dc.type | Article | |
